1. Introduction {#sec1-plants-09-00757}
===============

Malignant melanoma is the deadliest skin cancer type that originates from pigment-producing cells known as melanocytes \[[@B1-plants-09-00757]\]. It is caused by multiple and progressive DNA damage related to proto-oncogene activation, down-regulation of tumor suppressor genes, and structural changes of the chromosomes \[[@B2-plants-09-00757]\]. The etiology of all cancers depends on the interplay between genetic and environmental factors \[[@B3-plants-09-00757]\], and approximately 60--70% of malignant melanomas are presumed to be caused by ultraviolet (UV) radiation exposure \[[@B4-plants-09-00757]\]. Since malignant melanomas have been treated by surgical removal, cryosurgery, radiation therapy, or chemotherapy, there has been a growing interest in the use of complementary and alternative medicines because of the disadvantages mediated by conventional cancer chemotherapies and the health benefits of phytochemicals \[[@B5-plants-09-00757]\]. Different mechanisms and pathways are regulated by the anti-melanoma activity of phytochemicals, such as increased apoptosis, caspase activity, and expression of *p53* and Bcl-2-associated X protein (*bax*), and the inhibition of angiogenesis and tumor-promoting proteins \[[@B5-plants-09-00757]\]. The functional diversity of phytochemicals should provide unique and renewable resources to discover and develop potential new antitumor agents, suggesting that the investigation of biological and pharmaceutical properties of medicinal plants and their natural products is an important issue in the development of complementary or adjunctive therapies.

*Abeliophyllum distichum* Nakai is a deciduous flowering shrub, a monotypic genus with a single species of deciduous shrub in the olive family \[[@B6-plants-09-00757]\]. Although *A. distichum* has been used as a horticultural crop because of its ornamental value, the pharmaceutical properties of *A. distichum* extracts have been recently revealed, such as the anti-inflammatory effect \[[@B7-plants-09-00757]\], antioxidant activity \[[@B6-plants-09-00757]\], DNA damage inhibition \[[@B8-plants-09-00757]\], whitening property \[[@B9-plants-09-00757]\], anti-diabetic effect by inhibiting aldose reductase \[[@B10-plants-09-00757]\], antihypertensive activity \[[@B11-plants-09-00757]\], and anti-proliferative activity against human colorectal cancer cells \[[@B12-plants-09-00757]\]. Additionally, phytochemical investigations of *A. distichum* have revealed the presence of multiple active ingredients, such as acteoside, eutigoside B, isoacteoside, rutin, cornoside, hirsutrin, chlorogenic acid, caffeic acid, gentisic acid, ferulic acid, and quercetin \[[@B6-plants-09-00757],[@B10-plants-09-00757],[@B11-plants-09-00757]\], indicating the potential of *A. distichum* to be developed as a phytomedicine and a source to develop anti-melanoma agents, although no systematic study exists regarding the anti-melanoma action of *A. distichum*.

Therefore, in this study, the methanol extracts of *A. distichum* fruit, branches, and leaves were analyzed to assess the anti-melanoma effect of *A. distichum*, as well as to identify and quantify polyphenolic compounds, using high-performance liquid chromatography (HPLC). Additionally, to investigate the possible mechanism of anti-melanoma action of *A. distichum* extract, we performed pathway enrichment analysis of the differentially expressed genes (DEGs) in response to *A. distichum* extract.

2. Results {#sec2-plants-09-00757}
==========

2.1. Effects of A. distichum Organ Extracts on the Viability of Human Melanoma SK-MEL-2 Cells {#sec2dot1-plants-09-00757}
---------------------------------------------------------------------------------------------

The effect of the methanol extracts of leaves, branches, and fruit on the growth of human SK-MEL-2 melanoma cells was investigated using MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] assay. As shown in [Figure 1](#plants-09-00757-f001){ref-type="fig"}A, incubation with 50 μg/ml of *A. distichum* leaves (AL) (48.091 ± 12.741%) strongly inhibited the proliferation of SK-MEL-2 cells compared with *A. distichum* branches (AB) (84.229 ± 7.335%) and *A. distichum* fruits (AF) (86.949 ± 6.287%), although 200 μg/ml of all extracts showed similar cytotoxic activity. Therefore, AL was selected for further experiments. AL exhibited a dose- and time-dependent inhibitory effect on the viability of SK-MEL-2 cells ([Figure 1](#plants-09-00757-f001){ref-type="fig"}B). Although chemotherapeutic agents, including irinotecan, doxorubicin, oxaliplatin, and cyclophosphamide, have shown promising results alone or in combination with other cancer therapies, their unexpected activities against normal cells have led to harmful side effects \[[@B13-plants-09-00757]\]. Therefore, identifying and developing tumor-specific agents remains an outstanding challenge in cancer therapy. To investigate the effect of AL on the viability of normal cells and other melanoma cells, murine melanoma (B16F10) cells and adult human dermal fibroblasts (HDFa) were treated with different concentrations (50 μg/ml, 100 μg/ml and 200 μg/ml) of AL for 48 h. As shown in [Figure 1](#plants-09-00757-f001){ref-type="fig"}C, AL showed cytotoxic effects on B16F10 cells at concentrations of 50--200 μg/ml, but it was not cytotoxic against HDFa, even at the maximum tested concentrations. These findings indicate that AL can be a potent source of anticancer agents because of its selective cytotoxicity against melanoma cells and lack of toxicity in non-cancerous cells.

2.2. Composition of Polyphenolic Compounds in A. distichum Organ Extracts {#sec2dot2-plants-09-00757}
-------------------------------------------------------------------------

Polyphenolic compounds, including flavonoids and tannins, are beneficial plant compounds that offer various health benefits and are important anticancer agents \[[@B14-plants-09-00757]\]. Additionally, they are potential active compounds in *A. distichum* extract. To identify the active polyphenolic compounds that potentially exhibit cytotoxicity against melanoma cells, phenolic and flavonoid compounds were identified and quantified in *A. distichum* organ extracts using HPLC. Eighteen polyphenolic compounds, including chlorogenic acid, gallic acid, and luteolin, were identified in *A. distichum* organ extract ([Table 1](#plants-09-00757-t001){ref-type="table"}). AL (78.054 ± 0.307 mg/g of extract) and AF (36.012 ± 0.392 mg/g of extract) contain gallic acid ([Table 1](#plants-09-00757-t001){ref-type="table"}), which induces apoptosis in cancer cells \[[@B15-plants-09-00757]\]. Additionally, the highest amount of taxifolin, which exhibits promising pharmacological activities, including the management of tumors and liver disorders \[[@B16-plants-09-00757]\], was detected in AL (16.977 ± 0.167 mg/g of extract). Although AB exhibited a low level of cytotoxic activity compared with other extracts, various polyphenolic compounds, including kaempferol, rhamnetin, tangeretin, vanillic acid, and ferulic acid, have been identified. Taken together, the results show that the anti-melanoma activity of *A. distichum* organ extract should be mediated by these active polyphenolic compounds together with phytochemicals, which were not identified in this study. Additionally, differences in the anti-melanoma activity of organ extracts might be mediated by the different compositions of polyphenolic compounds.

2.3. AL Induces Caspase 8-dependent Apoptosis in SK-MEL-2 Cells {#sec2dot3-plants-09-00757}
---------------------------------------------------------------

Apoptosis and necrosis are highly conserved cell death mechanisms involved in the elimination of cancer cells by anti-cancer agents \[[@B17-plants-09-00757]\]. Distinguishing specific cell death subtypes is highly important to develop antineoplastic or other therapeutic drugs. To investigate the cell death type induced by AL, early-stage apoptotic cells and dead cells (late-stage apoptotic or necrotic cells) were discriminated using Annexin V/propidium iodide (PI) staining assay combined with fluorescence plate reader measurements. As shown in [Figure 2](#plants-09-00757-f002){ref-type="fig"}A, early-stage apoptotic cells and dead cells were significantly increased in SK-MEL-2 cells after AL treatment in a dose-dependent manner, suggesting that AL-induced cell death is comparable between early apoptotic and dead cells (late-stage apoptotic or necrotic cells) in SK-MEL-2 cells.

Reactive oxygen species (ROS), generated through various extracellular and intracellular actions, function as very important intracellular messengers involved in the growth, differentiation, progression, metabolism, and death of cells \[[@B18-plants-09-00757]\]. In cancer cells, low doses of ROS promote cell proliferation in various cancer cell types, although excessive levels of ROS activate several signaling pathways involved in cell apoptosis \[[@B19-plants-09-00757]\]. Therefore, ROS generation by phytochemicals has been closely associated with the induction of apoptosis in cancers \[[@B20-plants-09-00757]\]. To investigate whether AL-induced cell death is mediated by ROS accumulation, the intracellular ROS level in AL-treated cells was measured using the fluorogenic probe DCFH-DA. As shown in [Figure 2](#plants-09-00757-f002){ref-type="fig"}B, AL treatment did not result in the enhancement of intracellular ROS production, indicating that AL is a source of anticancer compounds that will not cause oxidative damage to normal cells.

Caspase-3, an intracellular cysteine protease, is the main executioner of apoptosis \[[@B21-plants-09-00757]\]. When SK-MEL-2 cells were treated with AL, caspase-3 activity was increased in a dose-dependent manner ([Figure 3](#plants-09-00757-f003){ref-type="fig"}A), indicating that AL suppressed the viability of SK-MEL-2 cells and led to programmed cell death through the modulation of caspase-3 activity. Caspase-3 activation is induced by caspase-8 and caspase-9, which are involved in the extrinsic and intrinsic apoptotic pathways, respectively \[[@B22-plants-09-00757]\]. To determine the underlying mechanism of AL-induced cell death, we analyzed the gene expression level of *caspase-8* and *caspase-9* in AL-treated SK-MEL-2 cells. An increased level of *caspase-8* and *caspase-3* expression was observed after AL treatment, whereas *caspase-9* expression was decreased ([Figure 3](#plants-09-00757-f003){ref-type="fig"}B). Additionally, down-regulation of the *Bax*/*Bcl-2* ratio, which regulates activation of the intrinsic apoptotic pathway \[[@B23-plants-09-00757]\], was observed after AL treatment, indicating that the extrinsic pathway triggers apoptosis in response to AL.

2.4. AL Induces Cell Death via the MEK-ERK Independent Pathway {#sec2dot4-plants-09-00757}
--------------------------------------------------------------

The mitogen-activated protein kinase (MAPK) pathway is essential in regulating cellular processes, including proliferation, differentiation, development, survival, and, under some conditions, also apoptosis \[[@B24-plants-09-00757]\]. Therefore, the involvement of MAPKs has been highlighted recently in various cell death-inducing models. To investigate the involvement of the MAPK pathway in AL-induced cell death, we analyzed the phosphorylation (activation) status of major MAPKs, MEK1/2 and ERK1/2. As shown in [Figure 4](#plants-09-00757-f004){ref-type="fig"}A, dynamic activation of MEK1/2 and ERK 1/2 was observed after AL treatment. Although several phytochemicals that can inhibit the MEK-ERK pathway have been suggested as potential cancer drugs \[[@B25-plants-09-00757]\], MEK-ERK-dependent multiple caspase activation is essential for mouse fibroblast and glioma cell death \[[@B26-plants-09-00757],[@B27-plants-09-00757]\]. Therefore, we presumed that activation of the MEK-ERK pathway is involved in AL-induced cell death. To test this hypothesis, SK-MEL-2 cells were co-treated with AL (100 μg/ml and 200 μg/ml) and the MEK1/2 selective inhibitor PD98059 for 48 h, and cell death was determined using MTT assay. PD98059 did not inhibit AL-induced cell death ([Figure 4](#plants-09-00757-f004){ref-type="fig"}B), suggesting that activation of the MEK-ERK pathway is not essential for the anticancer activity of AL against SK-MEL-2 cells.

2.5. AL Down-Regulates the Oncogenic Phosphoinositide 3-kinase (PI3K)/Akt Pathway in SK-MEL-2 Cells {#sec2dot5-plants-09-00757}
---------------------------------------------------------------------------------------------------

DEG analysis using RNA-seq is a powerful method that can explain the biological changes during the development of a new drug and describe the molecular mechanism of new agents according to the gene expression pattern \[[@B28-plants-09-00757]\]. To obtain a global overview of the molecular mechanisms involved in AL-induced cell death, total RNA was extracted from mock- or AL-treated cells and was used to generate transcriptome libraries on an Illumina HiSeq™ 2500 sequencing platform. After removing low-quality reads, 67 to 78 million clear reads (9.8 to 11.5 Gb) from each sample were acquired for DEGs analysis. By employing an RPKM (reads per kilobase per million mapped reads) cut-off of 0.05 to identify DEGs, 710 DEGs (182 up-regulated and 528 down-regulated) were detected comparing the mock- and AL-treated libraries ([Table S1](#app1-plants-09-00757){ref-type="app"}). To understand the universal response of SK-MEL-2 cells to 200 μg/ml of AL, all screened DEGs were subjected to gene ontology (GO) enrichment analysis, resulting in 54 functional groups classified into three categories: "cellular component", "molecular function", and "biological process" ([Figure S1](#app1-plants-09-00757){ref-type="app"}). The category "biological process", comprising 27 functional groups, exhibited the highest number of annotations alongside "cellular process", followed by "biological regulation", "metabolic process", and "regulation of biological process". Genes within the same pathway usually cooperate to exercise their biological function \[[@B29-plants-09-00757]\], suggesting that pathway enrichment is a useful strategy to help shed light on the biological mechanism. Pathway enrichment analysis of the identified DEGs revealed that DEGs were mostly enriched in the PI3K/Akt signaling pathway and Rap1 signaling pathway in SK-MEL-2 cells ([Figure S2A](#app1-plants-09-00757){ref-type="app"}). Among DEGs, nine genes, PDGFC, IGF1, KDR, IGF1R, PIK3R1, ITGB3, PDGFD, Akt3, and LPAR3, were involved in both the PI3K/Akt signaling pathway and Rap1 signaling pathway ([Figure S2B](#app1-plants-09-00757){ref-type="app"}), supporting that PI3K and Akt serve as downstream signaling molecules of Rap1 \[[@B30-plants-09-00757]\]. To validate the gene expression results from RNA-seq, the *Akt 3* expression ([Figure S3A](#app1-plants-09-00757){ref-type="app"}) and protein levels ([Figure S3B](#app1-plants-09-00757){ref-type="app"}) of Akt3 were analyzed using qRT-PCR and western blotting. As expected, *Akt3* showed a consistent expression pattern with its profile revealed using RNA-Seq ([Figure S3A](#app1-plants-09-00757){ref-type="app"}). The PI3K/Akt pathway signaling plays a significant role in the prevention of apoptosis by inhibiting caspase-dependent apoptosis \[[@B31-plants-09-00757],[@B32-plants-09-00757]\]. In SK-MEL-2 cells, most of the DEGs involved in the PI3K/Akt pathway were down-regulated by AL treatment ([Table 2](#plants-09-00757-t002){ref-type="table"}), suggesting that AL-induced caspase-8 and -3 might be mediated by down-regulation of the PI3K/Akt pathway.

3. Discussion {#sec3-plants-09-00757}
=============

Although cancer therapies have been performed throughout history, the efficacy and safety of treatment remain a challenge. Thus, medicinal plants and phytochemicals have been suggested as complementary treatments and primary sources of synthetic drugs. In this study, we have determined the anti-melanoma activity of *A. distichum* organ extracts and suggest that AL is a potent source of selective anticancer agents ([Figure 1](#plants-09-00757-f001){ref-type="fig"}). The difference in the anti-melanoma activity found here between different tested extracts should be due to the difference in the composition of phytochemicals, including polyphenolic compounds ([Table 1](#plants-09-00757-t001){ref-type="table"}). One possible explanation for the difference in the composition of polyphenolic compounds is the organ-specific expression of genes associated with polyphenolic compounds. The organ-specific expression pattern of anthocyanin biosynthesis-related genes affects the organ-specific accumulation of metabolites in *A. distichum* \[[@B33-plants-09-00757]\]. Additionally, other factors, such as catabolism, translocation, and feedback regulation, play important roles in the organ-specific accumulation of metabolites \[[@B34-plants-09-00757]\].

Caspases are a family of cysteine proteases that are responsible for apoptosis initiation and execution and can be activated via two main apoptotic signaling mechanisms: the intrinsic (mitochondrial) pathway and extrinsic (receptor-mediated) pathway \[[@B35-plants-09-00757]\]. In AL-treated SK-MEL-2 cells, we observed the enhanced activity of caspase-3 ([Figure 3](#plants-09-00757-f003){ref-type="fig"}A), which converges both apoptotic signaling pathways \[[@B21-plants-09-00757]\]. However, gene expression analysis indicated that AL induces cell death via activation of the extrinsic pathway ([Figure 3](#plants-09-00757-f003){ref-type="fig"}B). In human colorectal cancer cells, the ethyl acetate fraction of 80% methanol extract obtained from the plant parts of *A. distichum* including the flower, leaf, and branch induced transcriptional activation of activating transcription factor 3 (ATF3), resulting in apoptosis induction \[[@B12-plants-09-00757]\]. Various human cancers, including liver cancer, prostate cancer, colon cancer, and multiple myeloma, exhibit a low level of *ATF3* expression \[[@B36-plants-09-00757],[@B37-plants-09-00757],[@B38-plants-09-00757],[@B39-plants-09-00757]\]. Additionally, the knockdown mutation of *ATF3* promotes the development of prostate cancer through activation of PI3K/Akt signaling \[[@B40-plants-09-00757]\], which is crucial for the growth, survival, and development of prostate cancer cells \[[@B41-plants-09-00757]\] and suggests that ATF3 is a promising cancer preventive-therapeutic target. Similarly, we observed up-regulation of *ATF3* expression ([Table S1](#app1-plants-09-00757){ref-type="app"}), but down-regulation of the PI3K/Akt signaling pathway when SK-MEL-2 cells were treated with AL ([Table 2](#plants-09-00757-t002){ref-type="table"}). Interestingly, treatment with perifosine, an Akt inhibitor, induces extrinsic caspase-dependent cell death \[[@B42-plants-09-00757]\]. Additionally, gallic acid, the major compound identified from AL ([Table 1](#plants-09-00757-t001){ref-type="table"}), has been shown to inhibit the activation of Akt in OVCAR-3 cancer cells, resulting in the suppression of cell viability \[[@B43-plants-09-00757]\]. Furthermore, AL contained the highest content of taxifolin ([Table 1](#plants-09-00757-t001){ref-type="table"}), which suppressed the PI3K/Akt/mTOR pathway and scar cell carcinoma growth by inducing apoptosis \[[@B44-plants-09-00757]\]. Taken together, these results indicate that AL-induced cell death is mediated by down-regulation of the PI3K/Akt signaling pathway and activation of caspase 8-dependent apoptosis ([Figure 5](#plants-09-00757-f005){ref-type="fig"}).

4. Conclusions {#sec4-plants-09-00757}
==============

In conclusion, the results of the present study indicate the anti-melanoma potential of AL. AL positively or negatively regulates the complex network of signaling pathways involved in cell cytotoxicity, indicating that the activity described here may be caused by a combination of several potential anti-melanoma compounds. In addition, further study is necessary to analyze its effect on cancer animal models.

5. Materials and Methods {#sec5-plants-09-00757}
========================

5.1. Materials {#sec5dot1-plants-09-00757}
--------------

SK-MEL-2 human melanoma cells (ATCC® HTB-68™), B16F10 murine melanoma cells (ATCC® CRL-6475™), and HDFa human dermal fibroblasts (ATCC® PCS-201-012™) were purchased from ATCC (American Type Culture Collection, Manassas, Virginia, USA). Dimethyl sulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and 2',7'-dichlorofluorescein diacetate (DCFH-DA) were purchased from Duchefa (Seoul, Korea). RPMI 1640 medium, DMEM medium, penicillin, and fetal bovine serum (FBS) were purchased from Biowest (Riverside, MO, USA). The Pierce™ BCA Protein Assay Kit and SuperSignal™ West Pico PLUS Chemiluminescent Substrate were purchased from Thermo Fisher Scientific (Waltham, Massachusetts, USA). The antibodies for mitogen-activated protein kinase (MEK)1/2, phospho-MEK1/2 (Ser217/221), extracellular signal-regulated kinase (ERK)1/2, and phospho-ERK1/2 (Thr202/Tyr204) were obtained from Cell Signaling Technology (Beverly, Massachusetts, USA). The β-actin antibody was purchased from Santa Cruz Biotechnology, Inc. (Dallas, Texas, USA). The caspase-3 assay kit was purchased from Biovision (Milpitas, California, USA). The Annexin V FITC assay kit was purchased from Cayman Chemical (Ann Arbor, Michigan, USA).

5.2. Extraction and Sample Preparation {#sec5dot2-plants-09-00757}
--------------------------------------

*A. distichum* fruit, branches, and leaves were grown and taken from the research forest at Chungbuk National University. The fruit, branches, and leaves of *A. distichum* were lyophilized and ground into a fine powder using a blender. The ground materials were soaked in methanol for 24 h and subjected to ultrasonication (1 h × 3 times). After filtration, the methanol extracts of the fruit (AF), branches (AB), and leaves (AL) were evaporated using a rotary vacuum evaporator and kept in a refrigerator until use.

5.3. Cell Culture {#sec5dot3-plants-09-00757}
-----------------

SK-MEL-2 human melanoma cells, B16F10 murine melanoma cells, and HDFa human dermal fibroblasts were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and antibiotics or in DMEM medium with 10% FBS and antibiotics, at 37 °C in a humidified chamber containing 5% CO~2~.

5.4. Cell Viability Assay {#sec5dot4-plants-09-00757}
-------------------------

Cell viability was analyzed using MTT assay as described by Jin et al. \[[@B45-plants-09-00757]\]. Cells were plated in 96-well plates at a density of 2 × 10^4^ cells/well for SK-MEL-2 cells or 1 × 10^4^ cells/well for B16F10 cells or HDFa cells and then were cultured for 24 h. Next, the cells were treated with different concentrations (25 to 400 μg/ml) of each organ extract. After treatment for 48 h (or respective time points), 20 μL of MTT solution (1 mg/ml, diluted with phosphate-buffered saline (PBS)) were added and the cells were incubated in a CO~2~ incubator for an additional 4 h. The produced formazan dissolved with DMSO was quantified at 550 nm using an iMARK™ microplate reader (Bio-Rad, Hercules, CA, USA). An extract amount \< 50 μg/ml did not show significant cytotoxic activity, whereas \> 200 μg/ml of extracts exhibited similar cytotoxic activity compared to 200 μg/ml of extracts. Based on this finding, three different concentrations (50 μg/ml, 100 μg/ml, and 200 μg/ml) of each organ extract were used for further analysis.

5.5. Intracellular Reactive Oxygen Species (ROS) Measurement {#sec5dot5-plants-09-00757}
------------------------------------------------------------

Intracellular ROS were detected using the fluorogenic probe DCFH-DA as described by Warleta et al. \[[@B46-plants-09-00757]\] with minor modifications. SK-MEL-2 cells were exposed to different concentrations (50 μg/ml, 100 μg/ml, and 200 μg/ml) of AL for 5 h and then were stained with 20 µM DCFH-DA. After incubation in a CO~2~ incubator for 30 min, the cells were washed with PBS, and then DCF fluorescence was measured using a SpectraMAX Gemini EM Fluorescence Microplate Reader (Molecular Devices, San Jose, CA, USA) at the excitation and emission wavelengths of 485 nm and 525 nm, respectively.

5.6. Annexin V/propidium Iodide (PI) Staining Assay {#sec5dot6-plants-09-00757}
---------------------------------------------------

Early-stage apoptotic cells and dead cells were analyzed using an Annexin V FITC Assay Kit (Cayman Chemical, Ann Arbor, MI, USA) according to the manufacturer's instructions. Early-stage apoptotic cells stained using Annexin V FITC were detected with excitation and emission wavelengths of 560 nm and 595 nm, respectively, whereas dead cells stained using PI were detected with excitation and emission wavelengths of 485 nm and 535 nm, respectively, using a SpectraMAX Gemini EM Fluorescence Microplate Reader (Molecular Devices, San Jose, CA, USA).

5.7. Caspase-3 Activity {#sec5dot7-plants-09-00757}
-----------------------

Caspase-3 activity was analyzed using a Caspase-3/CPP32 Fluorometric Assay Kit (BioVision, Milpitas, CA, USA) according to the manufacturer's instructions. Fifty micrograms of protein obtained from mock- or AL-treated cells were mixed with each substrate and then incubated at 37 °C for 2 h. Caspase-3 activity was measured using a fluorescence microplate reader equipped with a 400-nm excitation filter and a 505-nm emission filter.

5.8. Western Blotting {#sec5dot8-plants-09-00757}
---------------------

Proteins were extracted from mock- or AL-treated cells using RIPA buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate, 1 mM ethylenediaminetetraacetic acid, and 10 mM NaF). The Pierce™ BCA Protein Assay Kit was used to quantify the proteins according to the manufacturer's instructions. Ten micrograms of protein were separated using 10% SDS-polyacrylamide gel electrophoresis (10% gel) and were transferred to a polyvinylidene fluoride membrane. After blocking using 5% nonfat dried milk, the membranes were incubated overnight at 4 °C with antibodies against MEK1/2, p-MEK1/2, ERK1/2, p-ERK1/2, and β-actin. The protein bands were subsequently visualized using ECL reagent (SuperSignal™ West Pico PLUS Chemiluminescent Substrate; Thermo Fisher Scientific, Carlsbad, CA, USA) and an Azure c280 imager (Azure Biosystems, Inc., Dublin, CA, USA).

5.9. RNA Sequencing and DEG Analysis {#sec5dot9-plants-09-00757}
------------------------------------

Total RNA extracted from mock- or AL-treated cells was quantified using a DeNovix DS-11 (DeNovix Inc, Wilmington, DE, USA). The cDNA library was synthesized and sequenced using an Illumina HiSeq™ 2500 sequencing platform. Adapter sequences, empty reads, low-quality reads (with ambiguous sequence, N), and reads with more than 10% Q \< 20 bases (i.e., with a base quality less than 20) were discarded from the raw sequencing data using the FastQC and Trimmomatic tools. Next, the clean reads were mapped to the *Homo sapiens* genome reference (*Homo sapiens* genome assembly GRCh38.p13) using an HISAT2 aligner. Transcript levels were calculated using SAMtools, and relative transcript abundances were analyzed using DEseq \[[@B47-plants-09-00757]\]. Statistically significant DEGs (*p* value cutoff of 0.05 and adjusting to \|log2 (fold change) \|≥ 1) were analyzed for gene ontology (GO) enrichment and pathway enrichment using the Blast2GO program and KOBAS v.3.0 Server, respectively. The statistical significance threshold level for all GO enrichment and pathway enrichment was *p* \< 0.05. All reads were deposited in the National Agricultural Biotechnology Information Center (NABIC, <http://nabic.rda.go.kr>) with accession number NN-6325 and NN-6326.

5.10. Quantitative Real-Time Polymerase Chain Reaction (qRT--PCR) {#sec5dot10-plants-09-00757}
-----------------------------------------------------------------

One hundred nanograms of total RNA were reverse transcribed into cDNA using a ReverTra Ace® qPCR RT Master Mix with qDNA Remover (TOYOBO Co., Ltd, Osaka, Japan) according to the manufacturer's instructions. qRT--PCR was performed using SYBR® Green Real-time PCR Master Mix (TOYOBO, Co., Ltd, Osaka, Japan) in a CFX96TM Real-Time System (Bio-Rad, Hercules, CA, USA). The relative expression levels of selected genes were normalized to the expression of the internal reference gene GAPDH. The specific primer pairs are listed in [Table S2](#app1-plants-09-00757){ref-type="app"}.

5.11. HPLC Analysis {#sec5dot11-plants-09-00757}
-------------------

HPLC analysis was performed using a Shimadzu liquid chromatography system (LC-10ADvp) coupled with an ultraviolet-visible detector (SPD-10A; Shimadzu, Japan). Separation was achieved using a Luna® HPLC column (C18(2) 100 Å, 250 × 4.6 mm, 5 μm) at 35 °C with a 0.7-ml/min flow rate. The mobile phases consisted of water containing 0.1% trifluoroacetic acid (mobile phase A) and acetonitrile containing 0.1% trifluoroacetic acid (mobile phase B). The following gradient elution was performed: 10% B in 0--0.01 min, 10--40% B in 0.01−28 min, 40--60% B in 28--39 min, 60--90% B in 39--50 min, and holding at 90% B for 5 min. The concentration was calculated by comparing the peak areas of the samples with the calibration curve of the standards.

5.12. Statistical Analysis {#sec5dot12-plants-09-00757}
--------------------------

All experiments were performed for three independent replicates, and the data were expressed as means ± standard error (SE). The significance of the between-group differences was determined using analysis of Duncan's multiple range test. Values of *p* \< 0.05 were considered significant.

The following are available online at <https://www.mdpi.com/2223-7747/9/6/757/s1>, Table S1. *Abeliophyllum distichum* leaves extract-induced DEGs, Table S2. Primer sequences for real-time PCR analysis, Figure S1. Gene ontology classification of *Abeliophyllum distichum* leaves extract-induced DEGs. Figure S2. KEGG pathway enrichment analysis using *Abeliophyllum distichum* leaves extract DEGs (A). Venn diagram analysis of DEGs involved in PI3K/Akt signaling pathway and Rap1 signaling pathway (B). Figure S3. The expression (A) and protein levels (B) of Akt3 in AL-treated SK-MEL-2 cells.
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![Anti-melanoma effect of methanol extracts obtained from *Abeliophyllum distichum* leaves (AL), fruit (AF), and branches (AB). (**A**) Effect of *A. distichum* organ extracts on the cell viability of SK-MEL-2 cells. SK-MEL-2 cells were treated with different concentrations of each extract for 48 h, and cell viability was determined using MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] assay. 10 μM of Quercetin was used as positive control. (**B**) Time and dose dependence of the anti-melanoma effect induced by AL. (**C**) Effect of AL on the cell viability of B16F10 murine melanoma cells and HDFa human dermal fibroblast cells. B16F10 cells and HDFa cells were treated with the indicated doses of AL for 48 h, and the viabilities of the cells were determined. The values are the means of three independent experiments, and the error bars represent the standard error. Values in the same column with different superscript letters are significantly different (*p* \< 0.05).](plants-09-00757-g001){#plants-09-00757-f001}

![Analysis of *Abeliophyllum distichum* leaves extract (AL)-induced apoptosis and ROS production in SK-MEL-2 cells. (**A**) Early apoptotic cells and dead cells (late-stage apoptotic or necrotic cells) were analyzed using a fluorescence reader after Annexin V and PI staining. (**B**) Intracellular ROS generation was detected in SK-MEL-2 cells after treatment with different concentrations of AL by staining with DCFH-DA. The data are expressed as means ± SE. Values with different superscript letters are significantly different (*p* \< 0.05).](plants-09-00757-g002){#plants-09-00757-f002}

![Effect of *Abeliophyllum distichum* leaves extract on caspase-3 activity and gene expression in SK-MEL-2 cells. The activity of caspase-3 (**A**) and expression of genes involved in the extrinsic and intrinsic apoptotic pathways (**B**) were analyzed after AL treatment for 48 h. The transcript level of each gene was normalized to the constitutive expression level of *GAPDH* and was expressed relative to the values of the mock-treated control. Data represent the means ± SE of three independent experiments. Different superscript letters represent significant differences compared with the mock-treated control (*p* \< 0.05).](plants-09-00757-g003){#plants-09-00757-f003}

![Effect of the MEK/ERK signaling pathway on *Abeliophyllum distichum* leaves extract (AL)-induced cell death. (**A**) The protein and activation levels of MEK1/2 and ERK1/2 were analyzed using western blotting after AL treatment. (**B**) Cell viability of SK-MEL-2 cells co-treated with AL and PD98059 for 48 h was assessed using MTT assay. Values in the same column with different superscript letters are significantly different (*p* \< 0.05).](plants-09-00757-g004){#plants-09-00757-f004}

![Schematic presentation of the probable molecular mechanism of *Abeliophyllum distichum* leaves extract (AL)-induced cell death. The red and blue boxes indicate the up- and down-regulated genes by AL treatment in SK-MEL-2 cells.](plants-09-00757-g005){#plants-09-00757-f005}

plants-09-00757-t001_Table 1

###### 

Polyphenolic compounds in *Abeliophyllum distichum* organ extracts.

                     Fruit                 Stem                  Leaf
  ------------------ --------------------- --------------------- --------------------
  Rutin              6.966 ± 0.073 ^c,1^   7.630 ± 0.150 ^b^     8.768 ± 0.013 ^a^
  Taxifolin          1.483 ± 0.019 ^c^     3.556 ± 0.027 ^b^     16.977 ± 0.167 ^a^
  Narirutin          5.110 ± 0.056 ^b^     1.447 ± 0.038 ^c^     9.727 ± 0.200 ^a^
  Naringin           3.715 ± 0.016 ^a^     ND                    ND
  Neohesperidin      ND                    ND                    0.401 ± 1.626 ^a^
  Myricetin          8.987 ± 0.329 ^b^     9.177 ± 0.204 ^a^     0.816 ± 0.079 ^c^
  Quercetin          ND                    4.758 ± 0.185 ^a^     ND
  Luteolin           3.220 ± 0.027 ^b^     252.818 ± 1.261 ^a^   1.442 ± 0.024 ^c^
  Naringenin         ND                    2.923 ± 0.575 ^a^     0.786 ± 1.391 ^b^
  Kaempferol         ND                    0.360 ± 0.014 ^a^     ND
  Isorhamnetin       ND                    7.383 ± 0.151 ^a^     7.041 ± 0.121 ^b^
  Rhamnetin          ND                    2.131 ± 0.019 ^a^     ND
  Tangeretin         ND                    5.068 ± 0.040 ^a^     ND
  Gallic acid        36.012 ± 0.392 ^b^    3.099 ± 0.042 ^c^     78.054 ± 0.307 ^a^
  Vanillic acid      ND                    0.217 ± 0.024 ^a^     ND
  Chlorogenic acid   0.605 ± 0.095 ^b^     ND                    3.960 ± 0.038 ^a^
  Ferulic acid       ND                    1.144 ± 0.305 ^a^     ND
  Sinapinic acid     ND                    16.093 ± 0.143 ^a^    1.001 ± 0.196 ^b^

^1^ mg/g of extract values are the average of triplicate experiments. Values with different superscript letters are significantly different between organ extracts (*p* \< 0.05). ND, not detected.

plants-09-00757-t002_Table 2

###### 

*Abeliophyllum distichum* leaves extract induces differentially expressed genes involved in the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway.

  Up/Down   Gene                                                                             Gene Description                    log2 (Fold Change)   *p*-Value
  --------- -------------------------------------------------------------------------------- ----------------------------------- -------------------- -----------
  Up        IL6R                                                                             interleukin 6 receptor              2.65                 0.0005
  CDKN1A    cyclin dependent kinase inhibitor 1A                                             1.82                                0.0049               
  NR4A1     nuclear receptor subfamily 4 group A member 1                                    1.36                                0.0282               
  Down      CASP9                                                                            caspase-9 isoform alpha precursor   −1.09                0.0023
  BCL2      apoptosis regulator Bcl-2 isoform alpha                                          −1.27                               0.0183               
  PDGFC     platelet derived growth factor C                                                 −1.29                               0.0366               
  IGF1      insulin like growth factor 1                                                     −1.32                               0.0349               
  IGF1R     insulin like growth factor 1 receptor                                            −1.33                               0.0429               
  ITGA2     integrin subunit alpha 2                                                         −1.34                               0.0386               
  TNN       tenascin N                                                                       −1.40                               0.0325               
  LAMA4     laminin subunit alpha 4                                                          −1.36                               0.0304               
  PIK3R1    phosphoinositide-3-kinase regulatory subunit 1                                   −1.45                               0.0186               
  ITGB3     integrin subunit beta 3                                                          −1.46                               0.0174               
  TNC       tenascin C                                                                       −1.68                               0.0355               
  LPAR3     lysophosphatidic acid receptor 3                                                 −1.76                               0.0154               
  PDGFD     platelet derived growth factor D                                                 −1.94                               0.0212               
  PPP2R2B   serine/threonine-protein phosphatase 2A regulatory subunit B                     −2.14                               0.0051               
  Akt3      AKT serine/threonine kinase 3                                                    −2.18                               0.0102               
  ITGB8     integrin subunit beta 8                                                          −2.22                               0.0005               
  THBS2     thrombospondin 2                                                                 −2.27                               0.0265               
  KDR       kinase insert domain receptor                                                    −2.70                               0.0028               
  YWHAE     tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon   −3.85                               0.00002              
